> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments on Extralable Drug Use Regulation
- URL: https://www.fdaweb.com/comments-on-extralable-drug-use-regulation/
- Published: 2017-06-27T12:00:00.000Z
- Updated: 2026-09-14T22:31:48.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139035

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Extralabel Drug Use in Animals — 21 CFR Part 530 OMB Control Number 0910–0325.” The regulation permits FDA, if it finds that there is a reasonable probability that the extralabel use of an animal drug may present a risk to the public health, to establish a safe level for a residue from the extralabel use of the drug, and to require the development of an analytical method for detecting residues above that established safe level. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-06-26/pdf/2017-13296.pdf?ref=fdaweb.com).